BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27530400)

  • 1. Amelogenesis imperfecta in familial hypomagnesaemia and hypercalciuria with nephrocalcinosis caused by CLDN19 gene mutations.
    Yamaguti PM; Neves FA; Hotton D; Bardet C; de La Dure-Molla M; Castro LC; Scher MD; Barbosa ME; Ditsch C; Fricain JC; de La Faille R; Figueres ML; Vargas-Poussou R; Houillier P; Chaussain C; Babajko S; Berdal A; Acevedo AC
    J Med Genet; 2017 Jan; 54(1):26-37. PubMed ID: 27530400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Claudin-16 Deficiency Impairs Tight Junction Function in Ameloblasts, Leading to Abnormal Enamel Formation.
    Bardet C; Courson F; Wu Y; Khaddam M; Salmon B; Ribes S; Thumfart J; Yamaguti PM; Rochefort GY; Figueres ML; Breiderhoff T; Garcia-Castaño A; Vallée B; Le Denmat D; Baroukh B; Guilbert T; Schmitt A; Massé JM; Bazin D; Lorenz G; Morawietz M; Hou J; Carvalho-Lobato P; Manzanares MC; Fricain JC; Talmud D; Demontis R; Neves F; Zenaty D; Berdal A; Kiesow A; Petzold M; Menashi S; Linglart A; Acevedo AC; Vargas-Poussou R; Müller D; Houillier P; Chaussain C
    J Bone Miner Res; 2016 Mar; 31(3):498-513. PubMed ID: 26426912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomagnesemia with Hypercalciuria Leading to Nephrocalcinosis, Amelogenesis Imperfecta, and Short Stature in a Child Carrying a Homozygous Deletion in the CLDN16 Gene.
    Radonsky V; Kizys MML; Dotto RP; Esper PLG; Heilberg IP; Dias-da-Silva MR; Lazaretti-Castro M
    Calcif Tissue Int; 2020 Oct; 107(4):403-408. PubMed ID: 32710267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family.
    Yuan T; Pang Q; Xing X; Wang X; Li Y; Li J; Wu X; Li M; Wang O; Jiang Y; Dong J; Xia W
    Calcif Tissue Int; 2015 Apr; 96(4):265-73. PubMed ID: 25555744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Vall-Palomar M; Madariaga L; Ariceta G
    Pediatr Nephrol; 2021 Oct; 36(10):3045-3055. PubMed ID: 33595712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Perdomo-Ramirez A; Aguirre M; Davitaia T; Ariceta G; Ramos-Trujillo E; ; Claverie-Martin F
    Gene; 2019 Mar; 689():227-234. PubMed ID: 30576809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex.
    Hou J; Renigunta A; Konrad M; Gomes AS; Schneeberger EE; Paul DL; Waldegger S; Goodenough DA
    J Clin Invest; 2008 Feb; 118(2):619-28. PubMed ID: 18188451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis: clinical and molecular characteristics.
    Claverie-Martin F
    Clin Kidney J; 2015 Dec; 8(6):656-64. PubMed ID: 26613020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease.
    Naeem M; Hussain S; Akhtar N
    Am J Nephrol; 2011; 34(3):241-8. PubMed ID: 21791920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin Loss-of-Function Disrupts Tight Junctions and Impairs Amelogenesis.
    Bardet C; Ribes S; Wu Y; Diallo MT; Salmon B; Breiderhoff T; Houillier P; Müller D; Chaussain C
    Front Physiol; 2017; 8():326. PubMed ID: 28596736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.
    Godron A; Harambat J; Boccio V; Mensire A; May A; Rigothier C; Couzi L; Barrou B; Godin M; Chauveau D; Faguer S; Vallet M; Cochat P; Eckart P; Guest G; Guigonis V; Houillier P; Blanchard A; Jeunemaitre X; Vargas-Poussou R
    Clin J Am Soc Nephrol; 2012 May; 7(5):801-9. PubMed ID: 22422540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset of chronic kidney disease: case report.
    Yamaguti PM; dos Santos PA; Leal BS; Santana VB; Mazzeu JF; Acevedo AC; Neves Fde A
    BMC Nephrol; 2015 Jul; 16():92. PubMed ID: 26136118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    Claverie-Martín F; García-Nieto V; Loris C; Ariceta G; Nadal I; Espinosa L; Fernández-Maseda Á; Antón-Gamero M; Avila A; Madrid Á; González-Acosta H; Córdoba-Lanus E; Santos F; Gil-Calvo M; Espino M; García-Martinez E; Sanchez A; Muley R;
    PLoS One; 2013; 8(1):e53151. PubMed ID: 23301036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity is a common ground in familial hypomagnesemia with hypercalciuria and nephrocalcinosis caused by CLDN19 gene mutations.
    Vall-Palomar M; Burballa C; Claverie-Martín F; Meseguer A; Ariceta G
    J Nephrol; 2021 Dec; 34(6):2053-2062. PubMed ID: 33929692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-19 localizes to the thick ascending limb where its expression is required for junctional claudin-16 localization.
    Dimke H; Griveau C; Ling WE; Brideau G; Cheval L; Muthan P; Müller D; Al-Shebel A; Houillier P; Prot-Bertoye C
    Ann N Y Acad Sci; 2023 Aug; 1526(1):126-137. PubMed ID: 37344378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
    García-Castaño A; Perdomo-Ramirez A; Vall-Palomar M; Ramos-Trujillo E; Madariaga L; Ariceta G; Claverie-Martin F
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1475. PubMed ID: 32869508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene.
    Al-Shibli A; Konrad M; Altay W; Al Masri O; Al-Gazali L; Al Attrach I
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):338-44. PubMed ID: 23538362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Claudin 19-based familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a sibling pair.
    Sharma S; Place E; Lord K; Leroy BP; Falk MJ; Pradhan M
    Clin Nephrol; 2016 Jun; 85(6):346-52. PubMed ID: 27007868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium.
    Hou J; Renigunta A; Gomes AS; Hou M; Paul DL; Waldegger S; Goodenough DA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15350-5. PubMed ID: 19706394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Acidification Does Not Explain the Absence of Nephrocalcinosis in a Mouse Model of Familial Hypomagnesaemia with Hypercalciuria and Nephrocalcinosis (FHHNC).
    Al-Shebel A; Michel G; Breiderhoff T; Müller D
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.